Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of COVID-19 in Patients With Severe Alpha-1 Antitrypsin Deficiency: The IMCA1 Study of the EARCO Clinical Research Collaboration.

Archivos de bronconeumologia - 1 Dec 2022

Parr David G, Chorostowska-Wynimko Joanna, Corsico Angelo, Esquinas Cristina, McElvaney Gerard N, Sark Annelot D, Sucena Maria, Tanash Hanan, Turner Alice M, Miravitlles Marc

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to alpha 1-Antitrypsin
Share to alpha 1-Antitrypsin Deficiency
Share to COVID-19

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phenotype

Source

Open in PubMed Open full text

Identifiers

PMID: 35879122
DOI: 10.1016/j.arbres.2022.07.002
PMCID: PMC9272568

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of COVID-19 in Patients With Severe Alpha-1 Antitrypsin Deficiency: The IMCA1 Study of the EARCO Clinical Research Collaboration.PMID 35879122Read ↗

α1-Antitrypsin deficiency and the risk of COVID-19: an urgent call to action.Semantic proximity Read ↗

Alpha-1 antitrypsin deficiency severity and the risk of COVID-19: A Portuguese cohortSemantic proximity Read ↗

Host genomics of COVID-19: Evidence point towards Alpha 1 antitrypsin deficiency as a putative risk factor for higher mortality rateSemantic proximity Read ↗

Standards for diagnosis and care of patients with inherited alpha-1 antitrypsin deficiency Recommendations of the Polish Respiratory Society, Polish Society of Pediatric Pulmonology and Polish Society of Pediatric Gastroenterology.Semantic proximity Read ↗

The European Alpha-1 Research Collaboration (EARCO): a new ERS Clinical Research Collaboration to promote research in alpha-1 antitrypsin deficiencySemantic proximity Read ↗

Current status of alpha-1-antitrypsin replacement therapy: recommendations for the management of patients with severe hereditary deficiency. Ad Hoc Committee on Alpha-1-Antitrypsin Replacement Therapy of the Standards Committee, Canadian Thoracic Society.Semantic proximity Read ↗

Role of the alpha-1 antitrypsin towards progression and severity of COVID- 19 infection among Saudi patientsSemantic proximity Read ↗

Alpha-1-antitrypsin antagonizes COVID-19: a review of the epidemiology, molecular mechanisms, and clinical evidenceSemantic proximity Read ↗

Alpha-1 antitrypsin deficiency.Semantic proximity Read ↗

APOE variants affect COVID-19 outcome.Semantic proximity Read ↗

Clinical features and natural history of severe alpha 1-antitrypsin deficiency. Roger S. Mitchell Lecture.Semantic proximity Read ↗

Role of the alpha-1 antitrypsin in the progression and severity of COVID-19 infection among Saudi patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.